Policy and Health Implications of Using the U.S. Food and Drug Administration Product Design Approach in Reducing Tobacco Product Risk

Publisher： Bentham Science Publishers

E-ISSN： 1874-4745|1|2|135-141

ISSN： 1874-4737

Source： Current Drug Abuse Reviews, Vol.1, Iss.2, 2008-06, pp. : 135-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health Risk Assessment Practices in the U.S. Food and Drug Administration

By Gaylor D.W.   Axelrad J.A.   Brown R.P.   Cavagnaro J.A.   Cyr W.H.   Hulebak K.L.   Lorentzen R.J.   Miller M.A.   Mulligan L.T.   Schwetz B.A.  

Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 3, 1997-12 ,pp. : 307-321

Academic Press

Access to resources Recommend Favorite

Auflistung der U.S. Food and Drug Administration: Pharmacogenomic Biomarkers in Drug Labels

By  

PHARMAKON, Vol. 1, Iss. 1, 2013-01 ,pp. : 36-39

Govi-Verlag

Access to resources Recommend Favorite

The US Food and Drug Administration and Emergency Contraception

By Fox Anthony W.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 3, 2005-01 ,pp. : 139-140

Adis International

Access to resources Recommend Favorite

US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids: Pros and Cons, and a European Perspective

By Mercadante Sebastiano  

Drugs, Vol. 72, Iss. 18, 2012-12 ,pp. : 2327-2332

Adis International

Access to resources Recommend Favorite

Natural Product and CAM Education in U.S. Pharmacy Schools: Comparison and Results of Two National Surveys

By Shields Kelly M.   Dutta Arjun P.   Daftary Monika N.   Ayuk-Egbe Patricia   McQueen Cydney E.   Bryant Patrick J.  

Journal of Pharmacy Teaching, Vol. 11, Iss. 2, 2005-02 ,pp. : 1-12

Haworth Press

Access to resources Recommend Favorite